Mabtech
Nacka
About Mabtech
Mabtech develop, manufacture, and market monoclonal antibodies and kits suited for ELISA, ELISpot and FluoroSpot.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Funding stage: M&A
- Last round: Debt Financing (Dec 2019)
- Website: mabtech.com
- Phone: +46 8 716 27 00
Industries & Categories
Biotechnology, Life Science, Manufacturing, Product Research, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/mabtech-2634892 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.